Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05099003 A Study of the Drug Selinexor With Radiation Therapy in Patients With N… |
Biopsy Procedure | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Australia, Canada, New Zealand · Alban… | 2022-05-31 → 2027-06-30 | Ouvrir |
| NCT07815262 ArtRehab — Study on the Efficacy and Safety of "Body-Tuning, Voice-Tuni… |
ArtRehab — Study on the Efficacy … | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Keda Yu | China · Shanghai Cancer Hospital, Fudan University, S… | 2026-04-01 → 2027-03-01 | Ouvrir |
| NCT04665765 Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide … |
carboplatin | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States · City of Hope Medical Center, Duarte, … | 2021-01-18 → 2027-06-28 | Ouvrir |
| NCT07401381 SIE-1 — A Study to Compare the Steady-State Bioavailability of Injectab… |
US-sourced oral Femara® + Letrozo… | Cancer | Phase 1 | RECRUITING | En attente / non publié | Rovi Pharmaceuticals Laboratories | United States, Serbia, Spain · Althaia Xarxa Assisten… | 2026-06-08 → 2028-10 | Ouvrir |
| NCT06303505 NAPISTAR1-01 — FiH Study to Investigate Safety, PK and Efficacy of the … |
TUB-040 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | Tubulis GmbH | United States, Belgium, Germany, Puerto Rico, Romania… | 2024-06-12 → 2027-12 | Ouvrir |
| NCT04381130 A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer |
EF-009 | Cancer | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Everfront Biotech Co., Ltd. | Non communiqué | 2027-04-01 → 2030-06-30 | Ouvrir |
| NCT07593079 Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Resi… |
Bicalutamide | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Washington University School of M… | United States · Washington University School of Medic… | 2026-10-31 → 2028-01-31 | Ouvrir |
| NCT07278739 Testing an Educational Program to Improve Goals of Care Conversations B… |
Testing an Educational Program to… | Cancer | Non applicable | RECRUITING | En attente / non publié | SWOG Cancer Research Network | United States · CARTI Cancer Center, Little Rock, Uni… | 2026-08-07 → 2032-07-21 | Ouvrir |
| NCT07815704 Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Ef… |
Targeting Immune Modulation in Hi… | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | University of Colorado, Denver | United States · University of Colorado Anschutz, Auro… | 2026-09 → 2031-08 | Ouvrir |
| NCT07729241 COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival |
COVICI-SURV: COVID-19 Vaccination… | Cancer | À vérifier | COMPLETED | En attente / non publié | Groupe Hospitalier Pitie-Salpetri… | France · Hôpital Pitié Salpêtrière / CIC-2503, Paris,… | 2020-12-28 → 2026-09-10 | Ouvrir |
| NCT05985954 Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib i… |
Cetuximab | Cancer | Phase 1 | RECRUITING | En attente / non publié | Verastem, Inc. | United States · M D Anderson Cancer Center, Houston, … | 2024-01-18 → 2028-03-28 | Ouvrir |
| NCT07104253 Establishing Feasibility of Transbronchial Cryoablation With an In-Deve… |
Ex vivo cryo-ablation | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Endocision Technologies Inc. | Non communiqué | 2026-12 → 2028-12 | Ouvrir |
| NCT07814365 PBI for Low-risk Breast Cancer |
3-week PBI | Cancer | Non applicable | RECRUITING | En attente / non publié | Fudan University | China · Fudan University Shanghai Cancer Center, Shan… | 2021-09-16 → 2031-09-16 | Ouvrir |
| NCT06345729 A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Partici… |
Calderasib | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Brazil,… | 2024-05-24 → 2031-02-18 | Ouvrir |
| NCT03845751 EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation The… |
HIFU hemi-ablation combined with … | Cancer | Phase 2 | UNKNOWN | En attente / non publié | Institut Mutualiste Montsouris | France · Institut Mutualiste Montsouris, Paris, France | 2023-01 → 2025-01 | Ouvrir |
| NCT03429582 Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablat… |
Standard C02 Cryotherapy | Cancer | Non applicable | COMPLETED | En attente / non publié | The Cleveland Clinic | China, El Salvador · Hospital Nacional de la Mujer, S… | 2020-10-30 → 2025-07-01 | Ouvrir |
| NCT03435770 Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancre… |
EUSRA RFA needle | Cancer | Non applicable | UNKNOWN | En attente / non publié | Singapore General Hospital | Singapore · Singapore General Hospital, Singapore, Si… | 2018-03-01 → 2019-09-01 | Ouvrir |
| NCT07226869 MWA Sim — Computer Guided Microwave Liver Ablation |
Computer-Assisted Microwave Liver… | Cancer | Non applicable | RECRUITING | En attente / non publié | NE Scientific INC | United States · Dartmouth Hitchcock Medical Center, L… | 2026-05-08 → 2030-02-28 | Ouvrir |
| NCT01786850 Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment o… |
Magnetic Resonance-guided High-in… | Cancer | À vérifier | AVAILABLE | En attente / non publié | University of Roma La Sapienza | Italy · Sapienza University of Rome, Policlinico Umbe… | Non communiqué | Ouvrir |
| NCT02082522 Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanc… |
Photodynamic therapy-Photofrin | Cancer | Phase 3 | TERMINATED | En attente / non publié | Concordia Laboratories Inc. | United States, Canada, Germany, South Korea, Switzerl… | 2014-11-12 → 2017-01-12 | Ouvrir |
| NCT07122258 Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Canc… |
CAROL NSCLC treatment Device | Cancer | Non applicable | RECRUITING | En attente / non publié | Tau Medical Australia Pty Ltd | Australia · Royal Melbourne Hospital, Melbourne, Aust… | 2026-03-01 → 2027-06-01 | Ouvrir |
| NCT07629206 Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment U… |
Cryoablation | Cancer | Non applicable | RECRUITING | En attente / non publié | Memorial Sloan Kettering Cancer C… | United States · Glendale Adventist Medical Center d/b… | 2026-07-17 → 2034-09 | Ouvrir |
| NCT05549960 LA-EUS MOD — Pre-planning Mathematical Models in EUS-guided Laser Ablat… |
The medical device used in this s… | Cancer | Non applicable | UNKNOWN | En attente / non publié | Campus Bio-Medico University | Italy · Serena Stigliano, Rome, Italy | 2023-02-01 → 2023-12-01 | Ouvrir |
| NCT03668652 FARP — Focal Prostate Ablation Versus Radical Prostatectomy |
Focal HIFU treatment using Focal … | Cancer | Non applicable | COMPLETED | En attente / non publié | Oslo University Hospital | Norway · Department of Cancer surgery, Oslo Universit… | 2017-09-30 → 2021-09-30 | Ouvrir |
| NCT06486454 Real-world Evaluation of the HistoSonics Edison System for Treatment of… |
Histotripsie — HistoSonics Edison… | Cancer | À vérifier | RECRUITING | En attente / non publié | HistoSonics, Inc. | United States · AdventHealth Altamonte Springs, Altam… | 2024-10-14 → 2039-11 | Ouvrir |